Chapter 12: Decompressive Craniectomy: Long Term Outcome and Ethical Considerations.

Area of Science:

• Neurosurgery
• Critical Care Medicine
• Trauma Surgery

Background:

• Decompressive craniectomy (DC) is a recognized intervention for severe traumatic brain injury (TBI), primarily aimed at reducing mortality.
• Despite established mortality benefits, significant clinical equipoise persists regarding the utility of DC in managing refractory intracranial hypertension.
• Recent large randomized trials present conflicting outcomes, suggesting potential harm or an increase in severely disabled survivors.

Purpose of the Study:

• To critically review recent clinical trial data on decompressive craniectomy for severe TBI.
• To elucidate the ongoing controversies surrounding the use of DC in refractory intracranial hypertension.
• To propose potential strategies for resolving the clinical dilemma associated with DC in TBI management.

Main Methods:

• Review of primary outcome data from major randomized clinical trials comparing DC with medical management for TBI.
• Analysis of secondary outcomes focusing on neurological disability and functional status of survivors.
• Synthesis of existing literature to identify key areas of debate and clinical equipoise.

Main Results:

• Evidence suggests DC effectively decreases mortality in severe TBI patients.
• However, data indicate that reduced mortality may correlate with a higher incidence of severe neurological incapacity.
• The overall benefit-risk profile of DC for refractory intracranial hypertension remains a subject of ongoing debate.

Conclusions:

• While DC reduces mortality in severe TBI, its role in improving functional outcomes is questionable.
• Further research and refined clinical guidelines are necessary to address the equipoise surrounding DC for refractory intracranial hypertension.
• Optimizing patient selection and post-operative care may be crucial for mitigating poor functional outcomes.